Surface Oncology, Inc. (SURF): Price and Financial Metrics

Surface Oncology, Inc. (SURF): $1.07

0.01 (-0.93%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

B

Add SURF to Watchlist
Sign Up

SURF Price/Volume Stats

Current price $1.07 52-week high $1.43
Prev. close $1.08 52-week low $0.56
Day low $1.01 Volume 1,510,100
Day high $1.09 Avg. volume 430,375
50-day MA $0.96 Dividend yield N/A
200-day MA $0.82 Market Cap 65.08M

SURF Stock Price Chart Interactive Chart >


Surface Oncology, Inc. (SURF) Company Bio


Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company’s lead product candidate is the SRF231 that is in Phase I clinical trial targeting protein called cluster of differentiation (CD) 47. It is also developing SRF373 inhibiting CD73; SRF617 inhibiting CD39; and SRF388, an antibody targeting interleukin 27. The company has a collaboration agreement with Novartis Institutes for Biomedical Research, Inc. for the development of cancer therapies. Surface Oncology, Inc. was founded in 2014 and is based in Cambridge, Massachusetts.


SURF Latest News Stream


Event/Time News Detail
Loading, please wait...

SURF Latest Social Stream


Loading social stream, please wait...

View Full SURF Social Stream

SURF Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!